www.inotivco.com Open in urlscan Pro
2606:2c40::c73c:67fe  Public Scan

Form analysis
1 forms found in the DOM

//www.inotivco.com/search-results

<form id="siq_searchForm" action="//www.inotivco.com/search-results">
  <input type="search" value="" name="s" class="hs-search-field__input" autocomplete="off" placeholder="What are you looking for?" data-uw-rm-form="fx" aria-label="What are you looking for?" data-uw-hidden-control="hidden-control-element">
  <a class="clear-input-btn" data-uw-rm-kbnav="anohref" tabindex="0">
            ×
          </a>
  <a class="submit-search-btn" aria-label="search" data-uw-rm-empty-ctrl="" data-uw-rm-kbnav="anohref" tabindex="0">
            <svg id="magnifying-glass" viewBox="0 0 16.9 16.9">
              <path d="M16.9,15.4l-4.7-4.7c2.2-3,1.6-7.2-1.4-9.5S3.5-0.3,1.3,2.7s-1.6,7.2,1.4,9.5c2.4,1.8,5.7,1.8,8.1,0l4.7,4.7
  L16.9,15.4z M6.8,11.5C4.1,11.5,2,9.4,2,6.8S4.1,2,6.8,2s4.8,2.1,4.8,4.8S9.4,11.5,6.8,11.5z"></path>
            </svg>
          </a>
</form>

Text Content

Skip to main contentEnable accessibility for visually impairedOpen the
accessibility menu Open the Accessible Navigation Menu







Cookie Preference

We use cookies to give you the best online experience, optimize site
functionality, analyze site traffic, provide personalized ads and content, and
assist in our marketing efforts. For more information see our cookie statement.

If you decline, your information won’t be tracked when you visit this website. A
single cookie will be used in your browser to remember your preference not to be
tracked.

Cookies Settings
AcceptDecline


Inotiv
 * Solutions
   * Discovery and Development
     * Research and Discovery
       * Computational Toxicology
       * Disease Pharmacology (in vitro and in vivo)
       * DMPK (in vitro and in vivo)
       * Safety Pharmacology
       * Cell and Molecular Biology
       * Discovery Bioanalysis
         * Biomarkers
       * Exploratory Toxicology
         * Toxicogenomics
         * Genetic Toxicology
         * General Toxicology
       * Surgical Models and Medical Device Testing
     * Pathology
       * Histology
       * Digital Pathology
       * Clinical Pathology
       * Medical Device Pathology
     * Nonclinical Safety Assessment
       * General Toxicology
       * Genetic Toxicology
       * Regulated Bioanalysis
         * Biotherapeutics
         * Biomarkers
       * DMPK (PK/TK)
       * Developmental and Reproductive Toxicology
       * Carcinogenicity Studies
       * Surgical Models and Medical Device Testing
     * Bioanalysis
       * Nonregulated Discovery Bioanalysis
       * Regulated Preclinical and Clinical Bioanalysis
       * Biotherapeutics
         * Biomarkers
     * Proteomics: Target Sufficiency®
     * Consulting
   * Research Models and Services
     * Models
       * Find Research Models
       * Models by Therapeutic Area
       * Model Sampling Program
       * Pricing
     * Research Services
       * Genetically Engineered Models and Services (GEMS)
       * Full Spectrum Health Monitoring
       * Custom Antibody Production Services
       * Biospecimen Services
       * Contract Breeding Services
       * Tumor Models and Services
       * Genetic Testing Services
       * Surgical Services
       * Research Model Support Services
     * Resources
       * Eusoft Labs™ (LIMS)
       * LabTracks™
   * Teklad™ Diet, Bedding and Enrichment
     * Teklad Laboratory Animal Diets
       * Standard Natural Ingredient Diets
       * Custom Research Diets
       * Medicated Diets
     * Bedding and Environmental Enrichment Products
       * Contact Bedding
       * Custom-cut Paper Cage Liners
       * Enrichment Products
     * Resources
       * Diet FAQs
       * Phytoestrogen References
       * Shelf Life of Diets Used In Research
     * Ordering
 * Insights
   * Scientific Insights
     * Learn More
   * Blog
     * Learn More
   * Resources
     * Cell Line References
     * Eusoft Labs™ (LIMS)
     * Health Monitoring Reports
     * LabTracks™
     * Safety Assessment Publications
     * Learn More
 * About
   * About
     * Why Inotiv
     * Leadership
     * News and Events
     * Global Reach
     * Environmental, Social and Governance (ESG)
     * Regulatory Compliance
     * Global Code of Conduct and Ethics
     * Animal Welfare Statement
     * Concordat on Openness
     * Company History
 * Investors

By Solutions By Therapeutic Area By Research Phase By Industry

|
 * Careers
 * Contact

 * Visit Our Virtual Booth


CLOSE ×
×
 * Solutions
   * Back
   * Solutions
   * Discovery and Development
     * Back
     * Discovery and Development
     * Research and Discovery
       * Back
       * Research and Discovery
       * Computational Toxicology
       * Disease Pharmacology (in vitro and in vivo)
       * DMPK (in vitro and in vivo)
       * Safety Pharmacology
       * Cell and Molecular Biology
       * Discovery Bioanalysis
         * Back
         * Discovery Bioanalysis
         * Biomarkers
       * Exploratory Toxicology
         * Back
         * Exploratory Toxicology
         * Toxicogenomics
         * Genetic Toxicology
         * General Toxicology
       * Surgical Models and Medical Device Testing
     * Pathology
       * Back
       * Pathology
       * Histology
       * Digital Pathology
       * Clinical Pathology
       * Medical Device Pathology
     * Nonclinical Safety Assessment
       * Back
       * Nonclinical Safety Assessment
       * General Toxicology
       * Genetic Toxicology
       * Regulated Bioanalysis
         * Back
         * Regulated Bioanalysis
         * Biotherapeutics
         * Biomarkers
       * DMPK (PK/TK)
       * Developmental and Reproductive Toxicology
       * Carcinogenicity Studies
       * Surgical Models and Medical Device Testing
     * Bioanalysis
       * Back
       * Bioanalysis
       * Nonregulated Discovery Bioanalysis
       * Regulated Preclinical and Clinical Bioanalysis
       * Biotherapeutics
         * Back
         * Biotherapeutics
         * Biomarkers
     * Proteomics: Target Sufficiency®
     * Consulting
   * Research Models and Services
     * Back
     * Research Models and Services
     * Models
       * Back
       * Models
       * Find Research Models
       * Models by Therapeutic Area
       * Model Sampling Program
       * Pricing
     * Research Services
       * Back
       * Research Services
       * Genetically Engineered Models and Services (GEMS)
       * Full Spectrum Health Monitoring
       * Custom Antibody Production Services
       * Biospecimen Services
       * Contract Breeding Services
       * Tumor Models and Services
       * Genetic Testing Services
       * Surgical Services
       * Research Model Support Services
     * Resources
       * Back
       * Resources
       * Eusoft Labs™ (LIMS)
       * LabTracks™
   * Teklad™ Diet, Bedding and Enrichment
     * Back
     * Teklad™ Diet, Bedding and Enrichment
     * Teklad Laboratory Animal Diets
       * Back
       * Teklad Laboratory Animal Diets
       * Standard Natural Ingredient Diets
       * Custom Research Diets
       * Medicated Diets
     * Bedding and Environmental Enrichment Products
       * Back
       * Bedding and Environmental Enrichment Products
       * Contact Bedding
       * Custom-cut Paper Cage Liners
       * Enrichment Products
     * Resources
       * Back
       * Resources
       * Diet FAQs
       * Phytoestrogen References
       * Shelf Life of Diets Used In Research
     * Ordering
 * Insights
   * Back
   * Insights
   * Scientific Insights
     * Back
     * Scientific Insights
     * Learn More
   * Blog
     * Back
     * Blog
     * Learn More
   * Resources
     * Back
     * Resources
     * Cell Line References
     * Eusoft Labs™ (LIMS)
     * Health Monitoring Reports
     * LabTracks™
     * Safety Assessment Publications
     * Learn More
 * About
   * Back
   * About
   * About
     * Back
     * About
     * Why Inotiv
     * Leadership
     * News and Events
     * Global Reach
     * Environmental, Social and Governance (ESG)
     * Regulatory Compliance
     * Global Code of Conduct and Ethics
     * Animal Welfare Statement
     * Concordat on Openness
     * Company History
 * Investors

 * Careers
 * Contact

 * Visit Our Virtual Booth


WHERE INSIGHTS LEAD TO ANSWERS IN DISCOVERY AND DEVELOPMENT


NOW AVAILABLE!


2024 PRODUCT GUIDE

Receive a copy of our current research models and services product guide.

Download now


QUANTIFY ANY PROTEIN, IN ANY SAMPLE, WITH ANY MODIFICATION, WITHOUT ANTIBODIES

Target Sufficiency® enables direct, quantitative analysis of drug target systems
in cells, biofluids, tissues, and tissue models, including formalin-fixed,
paraffin-embedded (FFPE) tissues.

Learn More


SUPPORTING YOUR CRITICAL RESEARCH WITH OUR INFLATION REDUCTION MODEL PROGRAM

Reduce costs with our complimentary sample for evaluation in your lab.

Claim Your Offer


CUSTOMIZED BIOMARKER AND BIOANALYTICAL SOLUTIONS THAT SUPPORT YOUR UNIQUE
BIOTHERAPEUTIC DEVELOPMENT

Learn More


COUNT ON OUR EXPERTISE IN IBD ANIMAL MODELS FOR YOUR NEXT IN VIVO STUDY

Discover More


SAMPLE OUR NEW BIOSECURE PLUS™ SOPF MODELS

Learn More


FUEL AND TEKLAD DIETS RAW MATERIAL SURCHARGE:

Learn More
 * 1
 * 2
 * 3
 * 4
 * 5
 * 6
 * 7




EXPECT MORE FROM YOUR DISCOVERY, DEVELOPMENT AND RESEARCH MODELS PARTNER

In Vivo Services In Vivo Services From discovery pharmacology and toxicology,
through regulated enabling safety assessment studies, our team has the in vivo
and analytical capabilities to deliver a variety of flexible solutions adaptable
to your needs. Histology Histology Our industry-leading histology laboratories
support your discovery and nonclinical development projects with a wide range of
services. From tissue processing to digital analysis, our team delivers the
quality you expect.   Pathology Pathology Access our world-class anatomical,
clinical, and medical device pathology team that provides services from
histochemistry to digital pathology including IHC, IF, and ISH to stereology,
and more.  DMPK DMPK From hit-to-lead to lead optimization through candidate
selection, our in vitro, in vivo, and bioanalytical teams offer the
fit-for-purpose solutions you need at any stage of development to help you
analyze, answer, and advance.  Consulting Consulting Our experts deliver the
insights you deserve to get the answers you need, whether in DMPK data analysis,
biomarker analysis, or bioequivalence studies. Research Models Research Models
Paired with the most comprehensive range of research models in the industry, we
offer the experience, quality, and consistency that is essential to your
success.  Research Model Services Research Model Services Our research model
services group provides high-quality support services worldwide, including
genetically engineered models and services (GEMS), contract breeding services,
surgical services, and more. Teklad Diet and Bedding Teklad Diet and Bedding
What comes out of your research depends in large part on what goes into your
research models. Ensuring study models have the most appropriate laboratory
animal diet, bedding, and enrichment is critical to maintaining consistent,
reliable data. 


EXPLORE OUR FULL OFFERING OF SERVICES AND PRODUCTS


DISCOVERY AND DEVELOPMENT 

Inotiv delivers a broad array of nonclinical and analytical services from
discovery through clinical development.  

Learn More


RESEARCH MODELS AND SERVICES 

Inotiv provides the broadest range of research models and related services to
pharmaceutical and biotech companies, government, academia, and other life
science organizations.  

Learn More


THE LATEST FROM INOTIV

Latest Events Latest News Insights

ON-DEMAND WEBINAR

NOT ALL IBD MODELS ARE CREATED EQUALLY

How Differences Between Experimental IBD Models Can Impact Your Drug Development
Program

SPEAK TO AN EXPERT

UTILIZE OUR EXPERTISE IN DART AND JUVENILE ANIMAL STUDIES (JAS) TO MEET YOUR
NEEDS



SCIENTIFIC POSTER

COMPARATIVE EVALUATION OF DIFFERENT PLATING METHODOLOGIES AND SOURCES OF INDUCED
S9 METABOLIC ACTIVATION ON THE MUTAGENIC POTENTIAL OF N-NITROSODIPROPYLAMINE
USING THE AMES TEST

Due to the current FDA concern and guidance on reducing the risk of Nitrosamine
impurities in human drugs, there has been an increased industry need for testing
of these impurities using the Bacterial Reverse Mutation (Ames) test. As
Nitrosamines are not readily detectable by standard Ames methodologies,
specifically cited in the Ames testing guideline (OECD 471), the need for a
robust protocol better suited for this class of compounds is warranted.

All Insights


ORTHOPEDIC RESEARCH SOCIETY (ORS)

February 2-6, 2024 Long Beach, CA Booth #17 We look forward to welcoming you to
Long Beach, CA, for the ORS 2024 Annual Meeting, where we will celebra...


SOCIETY OF TOXICOLOGY (SOT)

March 10-14, 2024 Salt Lake City, UT Booth #917 Join Inotiv scientists at SOT
held March 10-14, 2024, at the Salt Palace Convention Center in Salt Lak...

All Events


INOTIV REPORTS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS FOR FISCAL 2023
AND PROVIDES BUSINESS UPDATE

December 11, 2023 — Fiscal year 2023 revenue up 4.5% to $572.4 millio...


INOTIV, INC. ANNOUNCES PLAN TO INSOURCE NORTH AMERICAN TRANSPORTATION OPERATIONS

December 6, 2023 WEST LAFAYETTE, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv,
Inc. (Nasdaq: NOTV) (the “Company”), a...


INOTIV, INC. TO REPORT FISCAL 2023 FOURTH QUARTER AND FULL YEAR RESULTS AND HOST
CONFERENCE CALL ON MONDAY, DECEMBER 11, 2023

WEST LAFAYETTE, IN - November 27, 2023 -- Inotiv, Inc. (NASDAQ: NOTV) (the
“Company”, “We”, “Our” or “Inotiv”), a leading contract research organization
specializing in nonclinical and analyti...

All News

ON-DEMAND WEBINAR

NOT ALL IBD MODELS ARE CREATED EQUALLY

How Differences Between Experimental IBD Models Can Impact Your Drug Development
Program

SPEAK TO AN EXPERT

UTILIZE OUR EXPERTISE IN DART AND JUVENILE ANIMAL STUDIES (JAS) TO MEET YOUR
NEEDS



SCIENTIFIC POSTER

COMPARATIVE EVALUATION OF DIFFERENT PLATING METHODOLOGIES AND SOURCES OF INDUCED
S9 METABOLIC ACTIVATION ON THE MUTAGENIC POTENTIAL OF N-NITROSODIPROPYLAMINE
USING THE AMES TEST

Due to the current FDA concern and guidance on reducing the risk of Nitrosamine
impurities in human drugs, there has been an increased industry need for testing
of these impurities using the Bacterial Reverse Mutation (Ames) test. As
Nitrosamines are not readily detectable by standard Ames methodologies,
specifically cited in the Ames testing guideline (OECD 471), the need for a
robust protocol better suited for this class of compounds is warranted.

All Insights


ORTHOPEDIC RESEARCH SOCIETY (ORS)

February 2-6, 2024 Long Beach, CA Booth #17 We look forward to welcoming you to
Long Beach, CA, for the ORS 2024 Annual Meeting, where we will celebra...


SOCIETY OF TOXICOLOGY (SOT)

March 10-14, 2024 Salt Lake City, UT Booth #917 Join Inotiv scientists at SOT
held March 10-14, 2024, at the Salt Palace Convention Center in Salt Lak...

All Events


INOTIV REPORTS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS FOR FISCAL 2023
AND PROVIDES BUSINESS UPDATE

December 11, 2023 — Fiscal year 2023 revenue up 4.5% to $572.4 millio...


INOTIV, INC. ANNOUNCES PLAN TO INSOURCE NORTH AMERICAN TRANSPORTATION OPERATIONS

December 6, 2023 WEST LAFAYETTE, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv,
Inc. (Nasdaq: NOTV) (the “Company”), a...


INOTIV, INC. TO REPORT FISCAL 2023 FOURTH QUARTER AND FULL YEAR RESULTS AND HOST
CONFERENCE CALL ON MONDAY, DECEMBER 11, 2023

WEST LAFAYETTE, IN - November 27, 2023 -- Inotiv, Inc. (NASDAQ: NOTV) (the
“Company”, “We”, “Our” or “Inotiv”), a leading contract research organization
specializing in nonclinical and analyti...

All News

ON-DEMAND WEBINAR

NOT ALL IBD MODELS ARE CREATED EQUALLY

How Differences Between Experimental IBD Models Can Impact Your Drug Development
Program

SPEAK TO AN EXPERT

UTILIZE OUR EXPERTISE IN DART AND JUVENILE ANIMAL STUDIES (JAS) TO MEET YOUR
NEEDS



SCIENTIFIC POSTER

COMPARATIVE EVALUATION OF DIFFERENT PLATING METHODOLOGIES AND SOURCES OF INDUCED
S9 METABOLIC ACTIVATION ON THE MUTAGENIC POTENTIAL OF N-NITROSODIPROPYLAMINE
USING THE AMES TEST

Due to the current FDA concern and guidance on reducing the risk of Nitrosamine
impurities in human drugs, there has been an increased industry need for testing
of these impurities using the Bacterial Reverse Mutation (Ames) test. As
Nitrosamines are not readily detectable by standard Ames methodologies,
specifically cited in the Ames testing guideline (OECD 471), the need for a
robust protocol better suited for this class of compounds is warranted.

All Insights


SUBSCRIBE TO UPDATES FROM INOTIV

Sign up and you’ll receive the latest updates that matter to you, delivered
straight to your inbox.

Subscribe now  

Inotiv

 * 
 * 

Copyright © 2024 Inotiv. All Rights Reserved.

 * Terms of Use
 * Privacy Policy
 * Do Not Sell Or Share My Information
 * Accessibility Statement
 * Cookie Statement


Please ensure Javascript is enabled for purposes of website accessibility
ShareThis Copy and Paste